Oxford Asset Management’s Galmed Pharmaceuticals GLMD Stock Holding History

Oxford Asset Management’s Portfolio GLMD Stock Details GLMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-179	Closed	-$220K	–	1776
2018 Q4	$220K	Buy	+179	New	+$313K	0.01%	1510

Other funds holding GLMD

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return

Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

First Midwest Bank Trust Division Joliet, Illinois $777M AUM 29.48% 1-Year Est. Return

P.A.W. Capital Greenwich, Connecticut $88.2M AUM 25.13% 1-Year Est. Return

Oxford Asset Management's GLMD Position: Q1 2019 in Review

Oxford Asset Management sold out of Galmed Pharmaceuticals (GLMD) in Q1 2019, closing a stake of 179 shares — an estimated $220K sold.

Oxford Asset Management first reported a position in GLMD in Q4 2018 and held it in 1 quarter. The position peaked at $220K in Q4 2018. 34 funds tracked by Wall St. Rank hold GLMD as of Q1 2019.

Oxford Asset Management reported no remaining Galmed Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
Oxford Asset Management sold 179 Galmed Pharmaceuticals shares in Q1 2019, an estimated $220K.
Oxford Asset Management first reported a position in Galmed Pharmaceuticals in Q4 2018 and held it in 1 quarter.
Oxford Asset Management's Galmed Pharmaceuticals position peaked at $220K in Q4 2018.
34 funds tracked by Wall St. Rank held Galmed Pharmaceuticals as of Q1 2019.

Based on Oxford Asset Management's 13F filing for Q1 2019, filed 15 May 2019.